US 8865717
Heterocyclic compounds
granted A61PA61P25/00A61P25/14
Quick answer
US patent 8865717 (Heterocyclic compounds) held by Takeda Pharmaceutical Company Limited expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P25/00, A61P25/14, A61P25/16, A61P25/18